This week, the Food and Drug Administration (FDA) approved another generic version of mifepristone, one of the two drugs used in medication abortion. With this approval, three U.S. companies are now authorized to manufacture the medication: Danco Laboratories, which first received FDA approval in 2000; GenBioPro, which secured approval of the first generic in 2019; and now Evita Solutions. The… (Eisen, October 3, 2025) #Generic Drugs, #Women’s Health